Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8817977 | Health Policy | 2018 | 6 Pages |
Abstract
Overall savings observed in real-life from generic ARV drugs in Denmark were related to high rate of low-price generic utilization, contrarily to France and Czech Republic where these were more related to brand price-reduction than generic utilization itself.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Joseph Rwagitinywa, Agnès Sommet, Aurore Palmaro, Jean-Louis Montastruc, Maryse Lapeyre-Mestre,